Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Twist Bioscience Corporation (NASDAQ: TWST) has captured the attention of investors with its innovative approach to synthetic DNA-based products. Operating within the healthcare sector, specifically in the diagnostics and research..
SS Innovations International Inc. (NASDAQ: SSII), a promising player in the healthcare sector, is capturing attention with its impressive 121.80% revenue growth. As a commercial-stage surgical robotics company, SS Innovations..
For investors eyeing the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a fascinating opportunity with both risks and significant upside potential. Based in Waltham, Massachusetts, this commercial-stage biopharmaceutical company..
Select Medical Holdings Corporation (NYSE: SEM) stands as a prominent player in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Mechanicsburg, Pennsylvania, the company operates a..
Investors eyeing the healthcare sector may find NovoCure Limited (NASDAQ: NVCR) a compelling prospect, especially given its potential upside of 132.37%. As a key player in the medical devices industry,..
QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, operates within the medical devices industry. Headquartered in San Diego, California, QuidelOrtho provides cutting-edge diagnostic testing solutions through its..
Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, has been capturing investor attention with its robust pipeline of innovative treatments for serious hematologic diseases. As the company continues to..
Alvotech (NASDAQ: ALVO) stands as a notable player in the healthcare sector, specializing in the development and manufacturing of biosimilar medicines. Based in Luxembourg, this company is making waves in..
Addus HomeCare Corporation (NASDAQ: ADUS) stands as a compelling player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $2.15 billion, Addus has..
Metsera, Inc. (NASDAQ: MTSR), a burgeoning player in the biotechnology sector, is capturing significant attention with its promising pipeline of treatments for obesity and related conditions. Based in New York..
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company headquartered in Rockville, Maryland, continues to capture investor attention as it navigates the complex landscape of central nervous system (CNS) treatments. With..
UFP Technologies, Inc. (UFPT) is making waves in the healthcare sector, particularly in the medical devices industry, with its innovative solutions. Based in Newburyport, Massachusetts, the company has carved a..
MoonLake Immunotherapeutics (Nasdaq: MLTX) has captured the attention of investors with its promising pipeline in the competitive biotechnology sector. Based in Zug, Switzerland, this clinical-stage biotech firm is on the..
LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling opportunity for investors seeking exposure to innovative medical technologies. Headquartered..
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology sector with an impressive trajectory of developing and commercializing treatments for rare diseases. As an investor, understanding the company’s current..
Galapagos NV (NASDAQ: GLPG), headquartered in Mechelen, Belgium, draws investor attention within the dynamic biotechnology sector, focusing on groundbreaking medicines in oncology and immunology. With a market capitalization of $2.12..
ICU Medical, Inc. (NASDAQ: ICUI), a key player in the medical instruments and supplies industry, is drawing considerable attention from investors due to its promising potential upside of 40.29%. As..
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) has emerged as a notable player in the biotechnology sector with its focus on developing novel therapies for rare endocrine diseases and endocrine-related tumors. As..
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has positioned itself as an intriguing player in the biotechnology sector, particularly within the eye care segment. With its focus on developing therapeutic candidates for..
Investors seeking opportunities in the biotechnology sector might want to turn their attention to NewAmsterdam Pharma Company N.V. (NAMS). With its headquarters in Naarden, Netherlands, NewAmsterdam Pharma is carving out..
